October 16, 2014
Agripino is a 24-year-old man living in Guatemala. He is from a rural farming village where he works in the fields, although this has become difficult to do under his condition.
“Agripino came to us after several months of abdominal pain and distention,” our partners at Wuqu’ Kawog tell us. “We performed imaging studies which confirmed a tumor in his left kidney, consistent with kidney cancer. If not treated, this tumor will continue to grow and may even metastasize.”
It will take $1,475 to fund the chemotherapy necessary to battle Agripino’s cancer. Since his cancer has not yet progressed to an advanced stage and hasn’t metastasized, our partner’s expect the chemotherapy to be a cure! Our partners tell us that Agripino is “upbeat and optimistic, and looking forward to beating this thing” – lets come together and make that happen!
Agripino is a 24-year-old man living in Guatemala. He is from a rural farming village where he works in the fields, although this has become...
Read more
February 12, 2015
Agripino received surgery and chemotherapy to help cure his kidney cancer.
His doctor reports, “Agripino is doing really well. The first stage of his treatment was a huge surgery to remove the tumor. This was a very tricky operation, and he was in the hospital for several weeks. He got through that and is now back home and initiating the chemotherapy part of his treatment. He feels very well. Now that the tumor has been removed, most of the pain and discomfort are gone. He will be under treatment now for several more months to come but the ‘worst of it’ is behind him! We anticipate a continued good response to treatment and a remission of the cancer.”
Agripino says, “I am glad to be back home and strong enough to enjoy the upcoming holiday season with my family. Without you, I wouldn’t have been able to get any treatment at all. I trust in God that I will be fully cured.”
His doctor reports, "Agripino is doing really well. The first stage of his treatment was a huge surgery to remove the tumor. This was a very...
Read more